ZCI
REGN icon

Zevenbergen Capital Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Zevenbergen Capital Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-74,197
Closed -$25.6M – 85
2018
Q2 		$25.6M Sell
74,197
-49,850
-40% -$15.6M 0.85% 36
2018
Q1 		$42.7M Sell
124,047
-5,618
-4% -$1.95M 1.64% 25
2017
Q4 		$48.7M Sell
129,665
-13,020
-9% -$5.27M 2.03% 21
2017
Q3 		$63.8M Sell
142,685
-3,925
-3% -$1.87M 2.77% 14
2017
Q2 		$72M Sell
146,610
-4,130
-3% -$1.81M 3.13% 13
2017
Q1 		$58.4M Buy
150,740
+4,764
+3% +$1.77M 2.69% 14
2016
Q4 		$53.6M Sell
145,976
-16,447
-10% -$6.25M 2.52% 15
2016
Q3 		$65.3M Buy
162,423
+1,445
+0.9% +$580K 2.68% 14
2016
Q2 		$56.2M Buy
160,978
+17,342
+12% +$6.68M 2.63% 14
2016
Q1 		$51.8M Buy
143,636
+12,825
+10% +$5.28M 2.34% 16
2015
Q4 		$71M Buy
130,811
+18,420
+16% +$9.98M 2.89% 10
2015
Q3 		$52.3M Sell
112,391
-40
-0% -$21.5K 2.24% 20
2015
Q2 		$57.4M Buy
112,431
+335
+0.3% +$163K 2.23% 21
2015
Q1 		$50.6M Buy
112,096
+104,836
+1,444% +$44.4M 2.12% 22
2014
Q4 		$2.98M Buy
+7,260
New +$2.86M 0.13% 41

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Zevenbergen Capital Investments's REGN Position: Q3 2018 in Review

Zevenbergen Capital Investments sold out of Regeneron Pharmaceuticals (REGN) in Q3 2018, closing a stake of 74,197 shares — an estimated $25.6M sold.

Zevenbergen Capital Investments first reported a position in REGN in Q4 2014 and held it in 15 quarters. The position peaked at $72M in Q2 2017. 645 funds tracked by Wall St. Rank hold REGN as of Q3 2018.

  • Zevenbergen Capital Investments reported no remaining Regeneron Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 74,197 Regeneron Pharmaceuticals shares in Q3 2018, an estimated $25.6M.
  • Zevenbergen Capital Investments first reported a position in Regeneron Pharmaceuticals in Q4 2014 and held it in 15 quarters.
  • Zevenbergen Capital Investments's Regeneron Pharmaceuticals position peaked at $72M in Q2 2017.
  • 645 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2018.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2018, filed 13 Nov 2018.